Picture of United Laboratories International Holdings logo

3933 United Laboratories International Holdings Cashflow Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareSpeculativeMid CapSuper Stock

Annual cashflow statement for United Laboratories International Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2019
December 31st
C2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
HKAS
HKAS
HKAS
HKAS
HKAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line8428821,2032,0073,344
Depreciation
Amortisation
Non-Cash Items27529721558.7-38.6
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital9.05-226-495-587-1,432
Change in Accounts Receivable
Change in Inventories
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities1,8011,5681,5432,0312,439
Capital Expenditures-384-531-482-818-1,411
Purchase of Fixed Assets
Other Investing Cash Flow Items-49.2698-105224-146
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities-433167-587-595-1,557
Financing Cash Flow Items-216-123-41.3-33.7-42.3
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities318-1,908-621-24.2-1,363
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash1,683-1683341,412-481